Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics - A Global Market Overview" report has been ...
Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...
El Mundo on MSN15h
Ozempic and Viagra, among the more than 80 drugs expected to work against Alzheimer's in the coming yearsIn phase II and phase III, there are several compounds targeting tau, especially monoclonal antibodies (such as E2814, ...
Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...
Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.
A team of scientists from the Chinese Academy of Sciences (CAS) and BGI Research has uncovered the intricate mechanisms by ...
In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...
Ionis Pharmaceuticals posted better-than-expected revenue in the third quarter, but faced challenges as it prepares to bring ...
A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.
Begin your TipRanks Premium journey today. Percheron Therapeutics (PERCF) Company Description: Antisense Therapeutics Ltd. engages in the research and development of novel antisense pharmacceuticals.
DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...
Researchers have used microcellular "drones" to deliver antisense oligonucleotide therapeutics to lung cancer cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback